Despite DDX41 having been recognized as a tumor-inhibitory gene in myeloid neoplasms, several experiments have assessed the predictive value of DDX41 mutations in myeloid neoplasms, yet the results remain inconclusive [6, 7]. This evidence concerns the gene DDX41 and myeloid neoplasm.